Anaplastic Large Cell Lymphoma: A Clinicopathologic Study of 53 Patients

References

• Lennert K., Feller A.C. Histopathology of non-Hodgkin's lymphomas (based on the updated Kiel classification). Springer, Berlin 1992
   Google Scholar
• Agnarsson B.A., Kadin E.K. Ki-1 positive large cell lymphoma. Am. J. Surg. Pathol 1988; 12: 264–274
   PubMed Web of Science ®Google Scholar
• Stein H., Herbst H., Anagnostopulos I., Niedobitek G., Dallenbach F., Kratzsch H.C. The nature of Hodgkin and Reed Steinberg cells, their association with EBV and their relationship to anaplastic large cell lymphoma. Ann. Oncol. 1991; 2: 33–38
   PubMed Web of Science ®Google Scholar
• Pileri S., Bocchia M., Baroni C.D., Martelli M., Falini B., Sabattini E., Gherlinzoni F., Amadori S., Poggi S., Mazza P., Burgio V., Zinzani P.L., Melilli G., Benni M., Saragoni L., Martelli M.F., Stein H., Mandelli F., Tura S. Anaplastic large cell lymphoma (CD30+/Ki-l+): results of a prospective clin-ico-pathologic study of 69 cases. Br. J. Haematol. 1994; 86: 513–523
   PubMed Web of Science ®Google Scholar
• Stein H., Mason D.J., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H., Schwarting R., Lennert K. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed Steinberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858
   PubMed Web of Science ®Google Scholar
• Stansfeld A.G., Diebold J., Kapanci Y., Kelenyi G., Lannert K., Mioduszewska O., Noel H., Rilke F., Sundstrom C., Van Unnik J. A. M., Wright D.H. Updated Kiel classification for lymphomas. Lancet 1989; 1: 292–293
   Web of Science ®Google Scholar
• Pileri S., Falini B., Delsol G., Stein H., Baglioni P., Poggi S., Martelli M.F., Rivano M.T., Meson D.Y., Stansfeld A.G. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-l+ with a high content of reactive histio-cytes). Histopatology 1990; 16: 383–391
   PubMed Web of Science ®Google Scholar
• Harris N., Jaffe E.S., Stein H., Banks P.M., Chan J. K. C., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K.C., Grogan T.M., Isaacson P.G., Knowles D.M., Mason D.Y., Muller-Hermelink H.K., Pileri S., Piris M.A., Ralfkiaer E., Warnke R.A. A Revised European-American Classification of Lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Cordell J.L., Falini B., Erber W.N., Ghosh A.K., Abdulaziz Z., Macdonald S., Pulford K. A. F., Stein H., Mason D.Y. Immunoenzymating labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984; 32: 219–229
   PubMed Web of Science ®Google Scholar
• Stein H., Gerdes J., Tippelmann G., Dienemann D., Schwarting R., O'Connor N., Pileri S., Pallesen G., Delsol G. Ki-1 lymphoma: experimental and clinical findings. Proceedings from the third International Conference of Malignant Lymphoma, Lugano, June, 10–131987
   Google Scholar
• Bagley C.M., Jr., DeVita V.T., Jr., Berard C.W. Advanced lymphosarcoma: intensive cyclic combination chemotherapy with cyclophosphamide, vincristine and prednisone. (1972). Ann. Intern. Med. 1972; 76M: 227–234
   Google Scholar
• Guglielimi C., Amadori S., Anselmo A.P., Baroni C.D., Biagini C., Cimino G., Papa G., Mandelli F. Sequential chemotherapy of high-grade non-Hodgkin's lymphoma with 5-flu-orouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine and prednisone (F-MACHOP). Cane. Invest. 1987; 5: 159–169
   PubMed Web of Science ®Google Scholar
• Klimo P., Connors J.M. MACOP-B chemotherapy for the treatment of the diffuse large cell lymphoma. Ann. Intern. Med. 1985; 102: 190–195
   Google Scholar
• Connors J.M., Hoskins P., Klasa R. VACOP-B: 12-week chemotherapy for advanced stage diffuse large cell lymphoma. Efficacy is sustained and toxicity reduced compared to MACOP-B. Proc. Am. Soc. Clin. Oncol. 1990; 9: 254, 670–685
   Google Scholar
• Chan J. K. C., Hui P.K., Leungs T.W., Lau W.H., McGuire L.J. Anaplastic large cell K-1 lymphoma: delineation of two morphological types. Histopatology 1989; 15: 11–34
   PubMed Web of Science ®Google Scholar
• Chott A., Kaserer K., Augustin I., Vesely M., Heinz R., Ohelinger W., Hanak H., Radaszkiewicz T. Ki-1 positive large cell lymphoma. A clinicopathologic study of 41 cases. Am. J. Surg. Pathol 1990; 14: 439–448
   PubMed Web of Science ®Google Scholar
• Nakamura S., Takagi N., Kojima M., Motoori T., Kitoh K., Osada H., Suzuky H., Ogura M., Kurita S., Oyama A., Ueda R., Takahashi T., Suchi T. Clinicopathologic study of large cell anaplastic lymphoma (Ki-1 positive large cell lymphoma) among the Japanese. Cancer 1991; 68: 118–129
   PubMed Web of Science ®Google Scholar
• Kadin M.E. Ki-1 positive anaplastic large cell lymphoma: a clinicopathologic entity. J. Clin. Oncol. 1991; 9: 533–536
   PubMed Web of Science ®Google Scholar
• Pileri S., Mazza P., Zinzani P.L., Poggi S., Paoletti G., Falini B., Tura S. Ki-1 lymphoma and Hodgkin's disease. Haematologica 1989; 74: 333–335
   PubMed Web of Science ®Google Scholar
• Pileri S., Sabattini E., Tazzari P.L., Gherlinzoni F., Zucchini L., Bigeena B., Leoncini L., Rosso R., Stein H., Falini B. Hodgkin's disease: update of findings. Haematologica 1991; 76: 175–182
   PubMed Web of Science ®Google Scholar
• Falini B., Pileri S., Martelli M.F. Histological and im-munohistological analysis of human lymphomas. Crit. Rev. Oncol. Hematol 1989; 9: 351–419
   PubMed Web of Science ®Google Scholar
• Shulman L.N., Frisard B., Antin J.K., Wheeler C., Pinkus G., Magauran N., Mauch P., Nobles E., Mashal R., Canellos G., Tung N., Kadin M. Primary ki-1 anaplastic large cell lymphoma in adults: clinical characteristics and therapeutic outcome. J. Clin. Oncol 1993; 11: 937–942
   PubMed Web of Science ®Google Scholar
• Falini B., Pileri S., Stein H., Dieneman D., Dallenbach F., Delsol G., Minelli O., Poggi S., Martelli M.F., Pallesen G., Palestra G. Variable expression of leukocyte common antigen (CD45) in CD30 (ki-1) -positive anaplastic large cell (ALC) lymphoma. Implication for the differential diagnosis between lymphoid and non lymphoid malignancies. Hum. Pathol 1990; 21: 624–629
   PubMed Web of Science ®Google Scholar
• Rosso R., Paulli M., Magrini U., Kindl S., Boveri E., Volpato G., Poggi S., Baglioni G., Pileri S. Anaplastic large cell lymphoma. CD30/Ki-l positive, expressing the CD-15/Leu-Ml antigen. Virchow's Archiv B 1989; 416: 229–235
   Google Scholar
• Truini M., Briskomatis A., Sabattini E., Poggi S., Gherlinzoni F., Zinzani P.L., De Vivo A., Falini B., Pileri S. Linfoma a grandi cellule anaplastiche, inquadramento concettuale e diagnostico. Pathologica 1994; 86: 589–601
   PubMedGoogle Scholar
• Leoncini L., Del Vecchio M.T., Kraft R., Megha T., Barbini P., Cevenini G., Pileri S., Tosi P., Cottier H. Hodgkin's disease and CD30 positive anaplastic large cell lymphomas: a continuous spectrum of malignant disorders. Am. J. PathoL 1990; 137: 1047–1052
   PubMed Web of Science ®Google Scholar
• Frizzera G. The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Semin. Diagn. Pathol. 1992; 9: 291–310
   PubMed Web of Science ®Google Scholar
• Pileri S.A. Controversies on Hodgkin's disease and anaplastic large cell lymphoma (1994). Haematologica 1994; 79: 299–310
   PubMedGoogle Scholar
• Carbone A., Gioghini A., Gattei V., Aldinucci D., Degan M., De Paoli P., Zagonel V., Pinto A. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell linese. Blood 1995; 85(3)780–789
   PubMed Web of Science ®Google Scholar
• Delsol G., Meggetto F., Brousset P., Cohen-Knafo E., Al Saati T., Rochaix P., Gorguet B., Rubin B., Voigt J.J., Chittal S. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD 21 antigen. Am. J. Pathol. 1993; 142(6)1729–38
   PubMed Web of Science ®Google Scholar
• Delsol G., Meggetto F., Lamant L., Brousset P., Al Saati T. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease. Proceedings of the VII meeting of the European association of haematopathology, Toledo, 1994
   Google Scholar
• Herbst H., Niedobitek G., Kneba M., Hummel M., Finn T., Anagnostopulos I., Bergholz M., Krieger G., Stein H. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am. J. Pathol. 1990; 137: 13–22
   PubMed Web of Science ®Google Scholar
• Herbst H., Stein H., Niedobitek G. Epstein-Barr virus and CD30+malignant lymphomas. Crit. Rev. Oncogen 1993; 4: 191–202
   PubMed Web of Science ®Google Scholar
• Penny R.J., Blaustein J.C., Longtine J.A., Pinkus G.S. Ki-1 positive large cell lymphomas, a heterogenous group of neoplasms. Cancer 1991; 68: 362–373
   PubMed Web of Science ®Google Scholar
• Greer J.P., Kinney M.C., Collins R.D., et al. Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J. Clin. Oncol. 1991; 9: 539–547
   PubMed Web of Science ®Google Scholar
• Kadin M.E., Sako D., Berliner N., et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lym-phoadenopaty. Blood 1986; 68: 1042–1049
   PubMed Web of Science ®Google Scholar
• Beljaards R.C., Meijer C. J. L. M., Scheffer E. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favourable prognosis. Cancer 1993; 71: 2097–2104
   PubMed Web of Science ®Google Scholar
• Santini G., Chisesi T., Contu A., Coser P., Sertoli M.R., Congiu A.M., Vespignani M., Morandi S., Manna A., Schintu G.M., Quaini R., Miglio L., Nati S., Rossi E., Vimercati R., Spieno M., Pungolino E., Damasio E., Rizzoli V. II mitoxantrone nella terapia del linfomi non-Hodgkin, esperienza del non-Hodgkin lymphoma co-operative study group (NHLCSG). Proceedings of the 34th Congress of the Italian Society of Haematology. 1993; SS 14, 24
   Google Scholar
• Fisher R.I., Gaynor E.R., Dahlberg S., Oken M.M., Grogan T.M., Mize E.M., Glick J.H., Coltman C.A., Jr., Miller T.P. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin lymphoma. JV. Engl. J. Med. 1993; 328: 1002–1008
   PubMed Web of Science ®Google Scholar
• Chadburn A., Cesarman E., Jagirdar J., Subar M., Mir R.N., Knowles D.M. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 1993; 72: 3078–3090
   PubMed Web of Science ®Google Scholar
• Kadin M.E. Ki-l/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy. J. Clin. Oncol 1994; 12(5)884–887
   PubMed Web of Science ®Google Scholar
• Le Beau M., Bitter M.A., Larson R.A., et al. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1 positive anaplastic large cell lymphoma. Leukemia 1989; 3: 866–870
   PubMed Web of Science ®Google Scholar
• Mason D.Y., Bastard C., Rimokh R., Dastugue N., Huret J.L., Kristoffersson U., Magaud J.P., Nezelof C., Tilly H., Vannier J.P., Hemet J., Warnke R. CD-30 positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35. Br. J. Haematol. 1990; 74: 161–168
   PubMed Web of Science ®Google Scholar
• Gordon B.G., Welsenburger D.D., Warkentin P.I., et al. Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients. Cancer 1993; 71: 257–263
   PubMed Web of Science ®Google Scholar
• Morris S.W., Kirstein M.N., Valentine M.B., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in Non-Hodgkin lymphoma. Science 1994; 263: 1281–1284
   PubMed Web of Science ®Google Scholar
• Falini B., Piled S., Pizzolo G., Durkop H., Flenghi L., Stirpe F., Martelli M., Stein H. CD 30(ki-l) molecule: a new cy-tokine receptor of the tumor necrosisfactor superfamily as a toll for diagnosis and immunotherapy. Blood 1995; 85(1)1–14
   PubMed Web of Science ®Google Scholar